DK3313383T3 - Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling - Google Patents

Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling Download PDF

Info

Publication number
DK3313383T3
DK3313383T3 DK16733400.2T DK16733400T DK3313383T3 DK 3313383 T3 DK3313383 T3 DK 3313383T3 DK 16733400 T DK16733400 T DK 16733400T DK 3313383 T3 DK3313383 T3 DK 3313383T3
Authority
DK
Denmark
Prior art keywords
xerostomy
relief
induced
radiation treatment
gum composition
Prior art date
Application number
DK16733400.2T
Other languages
English (en)
Inventor
Heidi Ziegler Bruun
Original Assignee
Fertin Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fertin Pharma As filed Critical Fertin Pharma As
Application granted granted Critical
Publication of DK3313383T3 publication Critical patent/DK3313383T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058Chewing gums
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/16Fluorine compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Confectionery (AREA)
  • Medicinal Preparation (AREA)
DK16733400.2T 2015-06-23 2016-06-23 Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling DK3313383T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015064074 2015-06-23
PCT/EP2016/064578 WO2016207299A1 (en) 2015-06-23 2016-06-23 Chewing gum composition for use in alleviation of xerostomia induced by radiotherapy treatment

Publications (1)

Publication Number Publication Date
DK3313383T3 true DK3313383T3 (da) 2022-12-12

Family

ID=53510843

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16733400.2T DK3313383T3 (da) 2015-06-23 2016-06-23 Tyggegummisammensætning til anvendelse til lindring af xerostomi-induceret af strålebehandling

Country Status (4)

Country Link
US (1) US10695292B2 (da)
EP (1) EP3313383B1 (da)
DK (1) DK3313383T3 (da)
WO (1) WO2016207299A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11071310B1 (en) * 2014-12-17 2021-07-27 Natalie Marie Lutz Oral therapy article, and methods of using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241090A (en) * 1978-12-21 1980-12-23 Life Savers, Inc. Non-adhesive chewing gums and method
US4906455A (en) * 1988-04-15 1990-03-06 Wm. Wrigley Jr. Company Method for treating xerostomia employing chewing gum containing relatively insoluble, hydrophobic, food-grade organic acid
US5474787A (en) * 1994-10-21 1995-12-12 The Wm. Wrigley Jr. Company Chewing gum containing a lecithin/glycerol triacetate blend
US5702687A (en) * 1995-10-03 1997-12-30 Church & Dwight Co., Inc. Chewing gum product with plaque-inhibiting benefits
AU2001281749A1 (en) * 2000-08-14 2002-02-25 Fertin Pharma A/S Method for preparation of chewing gum with customer acceptable taste
DE60223659T2 (de) 2001-03-23 2008-10-30 Gumlink A/S Einstufiges verfahren zur herstellung von kaugummi
US20030185884A1 (en) * 2002-04-01 2003-10-02 Singh Nikhilesh Nihala Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
WO2004004480A1 (en) * 2002-07-02 2004-01-15 Gumlink A/S Compressed resin moderated chewing gum
EP1495680A1 (en) * 2003-07-08 2005-01-12 Gum Base Co. S.p.A. Gum base for chewing gum
US7776831B2 (en) * 2006-02-01 2010-08-17 Weg Stuart L Use of antifungal compositions to treat upper gastrointestinal conditions
EP1946751A1 (en) 2007-01-22 2008-07-23 Documedica S.A. Carrageenan-based chewing gum
US9730865B2 (en) 2009-05-22 2017-08-15 Lubris, Llc Application and uses of PRG4 and therapeutic modulation thereof
DK2442668T3 (da) * 2009-06-19 2016-12-12 Fertin Pharma As Bufret gummibase til høj ph-frigivelse

Also Published As

Publication number Publication date
EP3313383B1 (en) 2022-10-05
EP3313383A1 (en) 2018-05-02
WO2016207299A1 (en) 2016-12-29
US20190060228A1 (en) 2019-02-28
US10695292B2 (en) 2020-06-30

Similar Documents

Publication Publication Date Title
DK3431105T3 (da) Medicinsk sammensætning til behandling af cancer
DK3558997T3 (da) Aminotriazolopyridinforbindelser og deres anvendelse til behandling af cancer
DK3377516T3 (da) Sammensætning til behandling af cancer
DK3389778T3 (da) Indretning til fotodynamisk behandling
DK3288581T3 (da) Fremgangsmåde til behandling af cancer
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3212226T3 (da) Sammensætninger og anvendelsesfremgangsmåder til behandling af metaboliske lidelser
DK3851537T3 (da) Behandling af hyperbilirubinæmi
DK3185957T3 (da) Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3882250T3 (da) Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser
DK3261726T3 (da) Sammensætning til behandling af acne
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
DK3200815T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3265087T3 (da) Fremgangsmåde til behandling med tradipitant
DK3189074T3 (da) Sammensætninger og metoder til behandling og forebyggelse af inflammation
DK3456330T3 (da) Cortexolon-17alpha-valerat til anvendelse ved behandling af tumorer
DK3110446T3 (da) Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme
DK3213752T3 (da) Sammensætning til behandling af cancerstamceller
DK3391902T3 (da) Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati
DK3204038T3 (da) Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus